Evidence map›Paper›PMID 29562493›Full record

ArticleCancer biomarkers : section A of Disease markers2018

Combining ctnnb1 genetic variability with epidemiologic factors to predict lung cancer susceptibility.

Xu Wang, Xiaochang Zhang, Lina Jin, Zhiguang Yang, Wei Li, Jiuwei Cui

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xu WangCancer and Stem Cell Center, First Affiliated Hospital, Jilin University, Changchun, Jilin 130061, China.
Xiaochang ZhangCancer and Stem Cell Center, First Affiliated Hospital, Jilin University, Changchun, Jilin 130061, China.
Lina JinSchool of Public Health, Jilin University, Changchun, China.
Zhiguang YangDivision of Thoracic Surgery, First Affiliated Hospital, Jilin University, Changchun, Jilin 130061, China.
Wei LiCancer and Stem Cell Center, First Affiliated Hospital, Jilin University, Changchun, Jilin 130061, China.
Jiuwei CuiCancer and Stem Cell Center, First Affiliated Hospital, Jilin University, Changchun, Jilin 130061, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEarly detection and diagnosis of lung cancer remain challenging but would improve patient prognosis. The goal of this study is to develop a model to estimate the risk of lung cancer for a given individual.

methodsWe conducted a case-control study to develop a predictive model to identify individuals at high risk for lung cancer. Clinical data from 500 lung cancer patients and 500 population-based age- and gender-matched controls were used to develop and evaluate the model. Associations between environmental variants together with single nucleotide polymorphisms (SNPs) of beta-catenin (ctnnb1) and lung cancer risk were analyzed using a logistic regression model. The predictive accuracy of the model was determined by calculating the area under the receiver operating characteristic (ROC) curve.

resultsPrior diagnosis of chronic obstructive pulmonary disease (COPD), pulmonary tuberculosis, family history of cancer, and smoking are lung cancer risk factors. The area under the curve (AUC) was 0.740, and the sensitivity, specificity, and Youden index were 0.718, 0.660, and 0.378, respectively.

conclusionOur risk prediction model for lung cancer is useful for distinguishing high-risk individuals.

Indexed as

AdultAgedbeta CateninCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansLung NeoplasmsMaleMiddle AgedPolymorphism, Single NucleotideRisk Factorsbeta CateninCTNNB1 protein, humanChinese populationctnnb1lung cancerrisk prediction modelsingle nucleotide polymorphism

Identifiers

PMID29562493
PMCPMC13078451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.